Literature DB >> 12834361

Structural transformations of oligomeric intermediates in the fibrillation of the immunoglobulin light chain LEN.

Pierre O Souillac1, Vladimir N Uversky, Anthony L Fink.   

Abstract

LEN is a kappaIV immunoglobulin light chain variable domain from a patient suffering from multiple myeloma but with no evidence of amyloid fibrils. However, fibrils are formed when LEN solutions are agitated under mildly destabilizing conditions. Surprisingly, an inverse concentration dependence was observed on the kinetics of fibril formation because of the formation of off-pathway soluble oligomers at high protein concentration. Despite the fact that most of the protein is present in the off-pathway intermediates at relatively early times of aggregation, eventually all the protein forms fibrils. Thus, a structural rearrangement from the non fibril-prone off-pathway oligomers to a more fibril-prone species must occur. A variety of techniques were used to monitor changes in the size, secondary structure, solvent accessibility, and intrinsic stability of the oligomers, as a function of incubation time. The structural rearrangement was accompanied by a significant increase of disordered secondary structure, an increase in solvent accessibility, and a decrease in intrinsic stability of the soluble oligomeric species. We conclude that fibrils arise from the oligomers containing a less stable conformation of LEN, either directly or via dissociation. This is the first fibrillating system in which soluble off-pathway oligomeric intermediates have been shown to be the major transient species and in which fibrillation occurs from a relatively unfolded conformation present in these intermediates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12834361     DOI: 10.1021/bi034652m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis.

Authors:  Young-Mi Hwang; Peter B Stathopulos; Kristin Dimmick; Hong Yang; Hamid R Badiei; Ming Sze Tong; Jessica A O Rumfeldt; Pu Chen; Vassili Karanassios; Elizabeth M Meiering
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

2.  A long-lived Aβ oligomer resistant to fibrillization.

Authors:  Mimi Nick; Yibing Wu; Nathan W Schmidt; Stanley B Prusiner; Jan Stöhr; William F DeGrado
Journal:  Biopolymers       Date:  2018-01-10       Impact factor: 2.505

3.  Role of glycosaminoglycan sulfation in the formation of immunoglobulin light chain amyloid oligomers and fibrils.

Authors:  Ruiyi Ren; Zhenning Hong; Haiyan Gong; Kate Laporte; Martha Skinner; David C Seldin; Catherine E Costello; Lawreen H Connors; Vickery Trinkaus-Randall
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

4.  Effects of succinylation on thermal induced amyloid formation in Concanavalin A.

Authors:  Valeria Vetri; Fabio Librizzi; Valeria Militello; Maurizio Leone
Journal:  Eur Biophys J       Date:  2007-06-07       Impact factor: 1.733

5.  Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation.

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

6.  Insulin fibril nucleation: the role of prefibrillar aggregates.

Authors:  M I Smith; J S Sharp; C J Roberts
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

Review 7.  Mysterious oligomerization of the amyloidogenic proteins.

Authors:  Vladimir N Uversky
Journal:  FEBS J       Date:  2010-06-10       Impact factor: 5.542

Review 8.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

Review 9.  Amyloid formation in light chain amyloidosis.

Authors:  Marina Ramirez-Alvarado
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

10.  Light chain amyloidosis - current findings and future prospects.

Authors:  Elizabeth M Baden; Laura A Sikkink; Marina Ramirez-Alvarado
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.